Author

Juan Román

Observed names: J Román, J. Roman

Observed institutions: Universidad de Granada, Institute of Pharmacology and Toxicology of the National Academy of Medical Sciences of Ukraine, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Marmara University

OpenAlex ID: A5069983709

The intestinal anti‐inflammatory effect of dersalazine sodium is related to a down‐regulation in IL‐17 production in experimental models of rodent colitis

2011 · D Camuesco, ME Rodríguez‐Cabezas, et al. · British Journal of Pharmacology · 40

Evaluation of Responsive Gene Expression as a Sensitive and Specific Biomarker in Patients with Ulcerative Colitis

2012 · Juan Román, Núria Planell, et al. · Inflammatory Bowel Diseases · 22

UR-1505, a New Salicylate, Blocks T Cell Activation through Nuclear Factor of Activated T Cells

2007 · Juan Román, Alberto Fernández de Arriba, et al. · Molecular Pharmacology · 19

The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition

2007 · Elvira Bailón, Desirée Camuesco, et al. · Biochemical Pharmacology · 15

UR-1505, a salicylate able to selectively block T-cell activation, shows intestinal anti-inflammatory activity in the chronic phase of the DSS model of rat colitis

2008 · Elvira Bailón, Mònica Comalada, et al. · Inflammatory Bowel Diseases · 10

The New Salicylate Derivative UR-1505 Modulates the Th2/Humoral Response in a Dextran Sodium Sulphate Model of Colitis That Resembles Ulcerative Colitis

2009 · Elvira Bailón, Juan Román, et al. · Journal of Pharmacological Sciences · 6

P268 Ur-1505, a New Salicylate Derivative, Shows Intestinal Anti-inflammatory Activity in the Chronic Phase of the Dss Model of Rat Colitis

2008 · E. Bailon, M. Comalada, et al. · Journal of Crohn s and Colitis Supplements

Works count: 7

Citation count: 112

H-index: 6

I10-index: 5